Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
Cancer cells adapt their metabolism to survive limited nutrient availability. Here, the authors show that in conditions of limited glucose or glutamine availability, pancreatic ductal adenocarcinoma cells can use collagen-derived proline to foster the TCA cycle and allow cell survival bothin vitro a...
Guardado en:
Autores principales: | Orianne Olivares, Jared R. Mayers, Victoire Gouirand, Margaret E. Torrence, Tristan Gicquel, Laurence Borge, Sophie Lac, Julie Roques, Marie-Noëlle Lavaut, Patrice Berthezène, Marion Rubis, Veronique Secq, Stéphane Garcia, Vincent Moutardier, Dominique Lombardo, Juan Lucio Iovanna, Richard Tomasini, Fabienne Guillaumond, Matthew G. Vander Heiden, Sophie Vasseur |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a73d2e74efe45e79489251d11428d7b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma
por: Angélina Acier, et al.
Publicado: (2021) -
The Matrikine Acetylated Proline-Glycine-Proline Couples Vascular Inflammation and Acute Cardiac Rejection
por: Gregory A. Payne, et al.
Publicado: (2017) -
Proline: the distribution, frequency, positioning, and common functional roles of proline and polyproline sequences in the human proteome.
por: Alexander A Morgan, et al.
Publicado: (2013) -
Proline modulates the Trypanosoma cruzi resistance to reactive oxygen species and drugs through a novel D, L-proline transporter.
por: Melisa Sayé, et al.
Publicado: (2014) -
Combined approaches for drug design points the way to novel proline racemase inhibitor candidates to fight Chagas' disease.
por: Armand Berneman, et al.
Publicado: (2013)